Previous studies have demonstrated that the interruption of IL18 function reduces atherosclerosis in mice [42], and loss-of-function mutations in CECR1 could lead to systemic vasculopathy or vasculitis [43]. This evidence concerns the gene ADA2 and atherosclerosis.